About bluejay diagnostics inc - BJDX
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally invasive point-of-care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focuses on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Indranil Dey on March 20, 2015 and is headquartered in Acton, MA.
BJDX At a Glance
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue
Acton, Massachusetts 01720
| Phone | 1-844-327-7078 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -6,848,483.00 | |
| Sector | Health Technology | Employees | 6 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
BJDX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.27 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.566 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | -0.034 |
BJDX Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,141,413.833 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
BJDX Liquidity
| Current Ratio | 4.882 |
| Quick Ratio | 4.882 |
| Cash Ratio | 4.615 |
BJDX Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -99.422 |
| Return on Equity | -117.02 |
| Return on Total Capital | -112.181 |
| Return on Invested Capital | -115.615 |
BJDX Capital Structure
| Total Debt to Total Equity | 2.168 |
| Total Debt to Total Capital | 2.122 |
| Total Debt to Total Assets | 1.82 |
| Long-Term Debt to Equity | 0.414 |
| Long-Term Debt to Total Capital | 0.405 |